Hypertension as a Major Risk Factor in Diabetic Patients on Hemodialysis and CAPD
作者： E. Ritz , C. Hasslacher , W. Tschöpe
DOI: 10.1007/978-3-642-73232-4_15
关键词:
摘要: The magnitude of the problem hypertension in diabetic patients is illustrated by Fig. 1. In Type I diabetics with no proteinuria, prevalence higher than age- and sex-matched cohorts general population. Hypertension increases progressively more advanced stages nephropathy. Even striking high nonproteinuric II diabetics, an observation which may be related — at least part to possible role insulin raising blood pressure as recently discussed many authors. progressive severity nephropathy such occurs diabetics.
springer.com
sci-hub.st 参考文章(12)
S. Challah, F. P. Brunner, A. J. Wing, Evolution of the Treatment of Patients with Diabetic Nephropathy by Renal Replacement Therapy in Europe over a Decade: Data from the EDTA Registry Springer, Boston, MA. pp. 365- 377 ,(1988) , 10.1007/978-1-4757-1974-1_43
C. E. Mogensen, Progression of Nephropathy in Long-Term Diabetics with Proteinuria and Effect of Initial Anti-Hypertensive Treatment Scandinavian Journal of Clinical & Laboratory Investigation. ,vol. 36, pp. 383- 388 ,(1976) , 10.1080/00365517609055274
Chr. Reisch, J. Mann, E. Ritz, Conversion enzyme inhibitors in the antihypertensive treatment of patients with renal insufficiency Deutsche Medizinische Wochenschrift. ,vol. 112, pp. 1249- 1252 ,(2008) , 10.1055/S-2008-1068230
E Ritz, C Strumpf, F Katz, A J Wing, E Quellhorst, Hypertension and cardiovascular risk factors in hemodialyzed diabetic patients. Hypertension. ,vol. 7, ,(1985) , 10.1161/01.HYP.7.6_PT_2.II118
S Anderson, H G Rennke, B M Brenner, Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat. Journal of Clinical Investigation. ,vol. 77, pp. 1993- 2000 ,(1986) , 10.1172/JCI112528
C Hasslacher, E Ritz, J Terpstra, G Gallasch, G Kunowski, C Rall, Natural history of nephropathy in type I diabetes. Relationship to metabolic control and blood pressure. Hypertension. ,vol. 7, ,(1985) , 10.1161/01.HYP.7.6_PT_2.II74
Ch. Hasslacher, W. Stech, P. Wahl, E. Ritz, Blood pressure and metabolic control as risk factors for nephropathy in type 1 (insulin-dependent) diabetes. Diabetologia. ,vol. 28, pp. 6- 11 ,(1985) , 10.1007/BF00276992
E. Ritz, C. Hasslacher, W. Tsch�pe, M. Koch, J. F. E. Mann, Hypertension in Diabetes mellitus Contributions To Nephrology. ,vol. 54, pp. 77- 85 ,(1987) , 10.1159/000413215
A. J. Wing, F. P. Brunner, H. Brynger, C. Jacobs, P. Kramer, N. H. Selwood, N. Gretz, Cardiovascular-related causes of death and the fate of patients with renovascular disease. Contributions To Nephrology. ,vol. 41, pp. 306- 311 ,(1984) , 10.1159/000429302
Ritz E, Strumpf C, Wing Aj, Katz F, Cardiovascular risk factors and cardiovascular death in haemodialysed diabetic patients. Proceedings of the European Dialysis and Transplant Association - European Renal Association. European Dialysis and Transplant Association - European Renal Association. Congress. ,vol. 21, pp. 202- ,(1985)